Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of inhaled CVT-301 (levodopa inhalation powder) for OFF episodes in Parkinson's disease
2012-005822-31Phase 2Completed
- Sponsor
- Civitas Therapeutics
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing CVT-301 high dose (Dose Level 2) with Placebo (2 arms). Started Mar 2013; status: completed.
02
Drugs
levodopa inhalation powder
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2012-005822-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005822-31.